NEPH 1.61 (+3.87%)
US6406714005• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. NEPH

Nephros (NEPH) Competitor Comparison

We are evaluating the key criteria listed to compare Nephros (NEPH) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

38 / 44

Gross Profits

37 / 40

Total Revenue

37 / 43

EBITDA

28 / 44

Free Cashflow

27 / 44

Quick Ratio

13 / 44

Earnings per Share

21 / 44

Dividend yield

0 / 13

Total Cash

41 / 44

Performance 3 years

39 / 44

Performance 5 years

38 / 44

Performance 10 years

37 / 44

Linearity 3 years

38 / 43

Linearity 5 years

35 / 44

Linearity 10 years

13 / 43

Total Rank

17 / 44

Dividend Rank

28 / 44

Valuation Rank

27 / 44

Piotroski Rank

29 / 44

Muliplier Rank

16 / 44

Linearity 3 years - NEPH ranking 38 / 43

These are the competitors of Nephros in the industry Medical Instruments & Supplies ranked by linearity 3 years
1. Cooper Companies COO
269.36
2. ResMed RMD
176.24
3. electroCore ECOR
44.19
4. Ansell PD1.F
43.38
5. Becton, Dickinson BDX
41.32
6. Steris STE
35.97
7. NexGel NXGL
32.89
8. Hologic HOLX
27.99
9. Alcon ALC
12.74
10. iRhythm Technologies IRTC
11.9
11. Pulse Biosciences PLSE
9.7
12. KORU Medical Systems KRMD
9.67
13. West Pharmaceutical Services WST
8.15
14. ICU Medical ICUI
5.78
15. Atrion ATRI
5.41
16. Utah Medical Products UTMD
5.2
17. Haemonetics HAE
4.61
18. Teleflex TFX
4.45
19. Repligen RGEN
3.99
20. Envista Holdings NVST
3.79
21. Baxter BAX
3.28
22. Merit Medical Systems MMSI
3.17
23. Masimo MASI
3.16
24. AtriCure ATRC
3.14
25. BioLife Solutions BLFS
3.04
26. OraSure Technologies OSUR
3.03
27. Dentsply Sirona XRAY
2.96
28. Akoya Biosciences AKYA
2.55
29. Intuitive Surgical ISRG
2.53
30. Harvard Bioscience HBIO
2.52
31. Staar Surgical STAA
2.36
32. Microbot Medical MBOT
2.24
33. AngioDynamics ANGO
2.15
34. NovoCure NVCR
2.02
35. Ekso Bionics Holdings EKSO
1.98
36. Predictive Oncology POAI
1.92
37. Warby Parker WRBY
1.91
38. Nephros NEPH
1.81
39. Femasys FEMY
1.52
40. NeuroMetrix NURO
1.51
41. LeMaitre Vascular LMAT
1.36
42. Pro-Dex PDEX
0.95
43. Glaukos GKOS
0.58
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.